Read More Pharma Industry News From lab validation to clinical execution: Adaptin Bio advances a novel glioblastoma therapy toward trials Find out how Adaptin Bio is moving a novel glioblastoma therapy from lab validation into early clinical execution and what this step means for brain cancer research. bySoujanya RaviJanuary 23, 2026